Wegovy maker to try and block cheaper weight loss pill launched in the US – The Journal
Wegovy maker to try and block cheaper weight loss pill launched in the US The JournalUS retailer Hims &…
Hims and Hers Health’s compounded Wegovy pill offering fuels market jitters
Feb 5 (Reuters) – Hims & Hers said it would begin offering compounded versions of Novo Nordisk’s Wegovy…
Hims launches $49 compounded copy of Wegovy weight-loss pill
By Amina Niasse NEW YORK, Feb 5 (Reuters) – Online telehealth company Hims and Hers Health will start…
SA sales of weight-loss drugs surge amid global rise in lawsuits
Sales of weight-loss drugs are sky-rocketing in South Africa, as it has in other parts of the world.…
Eli Lilly Soared by 39% in 2025, but Here’s Another Healthcare Stock to Buy in 2026
Eli Lilly’s (NYSE: LLY) share price jumped 39% in 2025, driven by investors eager to benefit from the…
Novo’s Wegovy pill tracks over 26,000 prescriptions
Jan 30 (Reuters) – Novo Nordisk’s Wegovy pill hits over 26,000 U.S. prescriptions in the second full week…
US FDA Approves First Daily Oral GLP‑1 Treatment for Weight Management, Showing Comparable Results to Injectable Therapy
The US Food and Drug Administration (FDA) has approved Novo Nordisk’s new once-daily pill for weight management, designed…
Roche Shares Rise After Obesity Drug Shows 18% Greater Weight Loss
This article first appeared on GuruFocus. Roche Holding AG (RHHBY) is beginning to show tangible progress in obesity…
How Will Ozempic and Wegovy Sales Aid NVO’s Upcoming Q4 Results?
Novo Nordisk NVO is a dominant player in the cardiometabolic space, mainly due to the encouraging uptake of its…
Sesame Launches Wegovy® Pill Through Collaboration With Novo Nordisk
Cash-pay platform brings transparent pricing and direct provider access to first and only oral GLP-1 weight loss medication…
This Healthcare Stock Could Soar by 40% in 2026
Novo Nordisk had a rough stretch in 2025 that eventually led to it “firing” its CEO. The new…
Ozempic Brings Back the ‘Mac vs PC’ Ads for the GLP-1 Era
Novo Nordisk’s Ozempic kicked off the GLP-1 craze when it launched in 2018 for the treatment of Type…